List of Contents

Orthopedic Biomaterials Market Size, Share, and Trends 2024 to 2034

The global orthopedic biomaterials market size is calculated at USD 24.5 billion in 2025 and is forecasted to reach around USD 46.32 billion by 2034, accelerating at a CAGR of 7.30% from 2025 to 2034. The North America orthopedic biomaterials market size surpassed USD 8.47 billion in 2024 and is expanding at a CAGR of 7.44% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1107
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Orthopedic Biomaterials Market, By Material

7.1. Orthopedic Biomaterials Market, by Material Type, 2024-2033
7.1.1. Polymers
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Ceramics & Bioactive Glasses
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Calcium Phosphate Cement
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Composites
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. Metal
7.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Orthopedic Biomaterials Market, By Application

8.1. Orthopedic Biomaterials Market, by Application, 2024-2033
8.1.1. Orthobiologics
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Orthopedic Implants
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Viscosupplementation
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Joint Replacement
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Bio-resorbable Tissue Fixation
8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Orthopedic Biomaterials Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Material (2021-2033)
9.1.2. Market Revenue and Forecast, by Application (2021-2033)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.1.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.5.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.5.4.2. Market Revenue and Forecast, by Application (2021-2033)

Chapter 10. Company Profiles

10.1. Acumed, LLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Globus Medical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Koninklijke DSM N.V.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Exactech, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Zimmer Biomet
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Wright Medical Group, Inc.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

 

12.1. About Us
12.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The orthopedic biomaterials market is projected to grow at a CAGR of 7.30%% for estimated period 2025 to 2034.

The global orthopedic biomaterials market size is expected to increase USD 46.32 billion by 2034 from USD 22.88 billion in 2024.

Increasing demand of orthopedic implants and rising injuries owing to sports and road calamities fuel the growth of global orthopedic biomaterials market. The damaged bone has been reconstructed by using biomaterials caused by diseases or trauma. High occurrences of musculoskeletal disease will also drive the market growth of orthopedic biomaterials. Furthermore, significant rise in adoption of technologically advanced products and growth of R&D activities will boost the capabilities of orthopedic biomaterials which will in turn drive their demand in the market.

The ceramics & bioactive glass segment dominated the market in 2024 as ceramics are widely adopted in repair of hard tissues in multiple procedures.

The orthopedic implant segment dominated the market in 2024 and continuous to dominate the market over the forecast period.

The growth in North America has been attributed to the increasing prevalence of various orthopedic surgeries. Growing number of patients requiring knee reconstruction or replacement and other orthopedic procedures are likely to enhance the growth of the market in the region.

Asia Pacific is projected to witness fastest growth rate in the global orthopedic biomaterials market over the forecast period. This growth is owing to increased bone degenerative and disorders in developing nations such as India and China.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us